Bond.az White LogoBond.az Black Logo

Creatd Boosts Vocal Stake to 51%

Creatd, Inc. increases ownership in Vocal platform to 51%, supporting its restructuring and uplisting strategy.

Robert Moore
ByRobert Moore- Senior Editor
|
0

Creatd, Inc. (OTCQB:CRTD) announced that it will increase its ownership stake in Vocal from 20% to 51%.

The move is part of Creatd's restructuring and uplisting plans.

Vocal, a creator platform with 30 million monthly visitors, is set to launch Vocal 3.0 with AI tools soon.

More News
Today / 13:45
|
500

Digitalbridge Group Stock Hits 52-Week High at $15.66

Digitalbridge Group stock hits 52-week high at $15.66. One-year gain 65%, six-month surge 63%. Bond.az analysis.

0
Today / 13:44
|
770

Pelagos Insurance stock hits all-time high at 21.96 USD

Pelagos Insurance Capital Ltd stock hits record high of 21.96 USD. Discover the latest financial results, dividend news, and rebranding details.

0
Today / 13:43
|
215

CNO Financial Group Stock Hits All-Time High of $46.61

CNO Financial Group stock hits all-time high of $46.61. Learn about the company's financial results and market outlook.

0
Today / 13:35
|
272

IP Strategy Regains Nasdaq Compliance

IP Strategy Holdings Inc. regains compliance with Nasdaq continued listing standards, meeting minimum bid price requirement.

0
Today / 13:33
|
963

JazzCash Hits 60M Users, Processes $59.7B

JazzCash reaches 60 million users, processes $59.7 billion in transactions. VEON stock up 17.4%.

0
Today / 12:34
|
347

Fiserv Projects Double-Digit EPS Growth Through 2029

Fiserv projects double-digit EPS growth through 2029. Get insights on medium-term financial targets, strategic priorities, and growth plans.

0
Today / 12:33
|
584

BitFuFu bitcoin production drops 32% in April

BitFuFu reported a 32% drop in bitcoin production in April 2026 to 145 BTC, citing a power outage in Ethiopia and contract expirations.

0
Today / 12:31
|
517

Cingulate Reports Q1 Loss

Cingulate Q1 2026 results: net loss $9.3M, cash at $25.9M. ADHD drug candidate CTx-1301 advances with FDA.

0
Today / 12:16
|
759

ENDRA liver device succeeds in multi-site trial

ENDRA Life Sciences announces positive multi-site clinical results for its TAEUS Liver device, showing high accuracy in measuring liver fat.

0
Today / 11:34
|
302

Accenture Federal Services partners with OpenAI

Accenture Federal Services partners with OpenAI to help U.S. agencies deploy AI with FedRAMP compliance and an Agentic Lab. Details on Bond.az.

0
Today / 11:21
|
812

Barb Gold Project Phase 1 Begins

Gunsynd starts phase 1 at Barb Gold Project in Manitoba, Canada. Field work runs from May 27 to June 2, 2026.

0
Today / 11:13
|
464

Proteome Sciences reports progress in services, reagent sales

Proteome Sciences plc reports progress in services business and continued recovery in TMT and reagent sales at AGM.

0
...